ConductScience.org, home

Gene · 2256

FGF11: fibroblast growth factor 11

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. FGF11: fibroblast growth factor 11. Genes, record 2256. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2256

On this page

Gene

Symbol
FGF11
HGNC
Name
fibroblast growth factor 11
HGNC
NCBI Gene ID
2256
NCBI Gene
HGNC ID
HGNC:3667
HGNC
Ensembl
ENSG00000161958
NCBI Gene
Aliases
FGF-11, FHF-3, FHF3, FLJ16061, MGC102953, MGC45269
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q92914Fibroblast growth factor 112250Ensembl, GeneID, HGNC

Source UniProt

Patents247

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
KR 1020230147484 A2023-10-231Q92914Espacenet
KR 1020230123701 A2023-08-242Q92914Espacenet
US 11504404 B22022-11-22126Q92914Espacenet
US 11446398 B22022-09-2031849Q92914Espacenet
JP 2022524081 A2022-04-27134820Q92914Espacenet
JP 2021169490 A2021-10-28212Q92914Espacenet
US 11078247 B22021-08-034011Q92914Espacenet
US 10584344 B22020-03-10126Q92914Espacenet
US 9878056 B22018-01-301260Q92914Espacenet
JP 2017141230 A2017-08-175328Q92914Espacenet

1 to 10 of 247

See all 247 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants235

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFGF11 papersNewest fiscal year
P30CA068485Cancer Center Support Grant22025
P30EY008126Core Grant in Vision Research22025
UL1TR001863Yale Clinical and Translational Science Award22025
I01BX004259Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss12025
P01AG036675Kynurenine accumulation drives loss of muscle and bone function with aging12025
P01AG036695Molecular Regulation of Stem Cell Aging12025
P30CA006973Regional Oncology Research Center12025
P30CA013148Comprehensive Cancer Center Support Grant12025
P30CA016087Cancer Center Support Grant12025
P30CA016672Cancer Center Support Grant12025

1 to 10 of 235Source NIH's project files

See all 235 nih grants

Papers416

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Unveiling differential gene expression and pathways in clear cell renal cell carcinoma with sarcomatoid transformation.PeerJ202642569572PubTator, text miningPubMed
Beyond Ion Channels: Emerging Roles of FGF12 in Cellular Regulation and Cancer Progression.Cells202641744813PubTator, text miningPubMed
Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.J Immunother Cancer202641545302PubTator, text miningPubMed
Pathology and Therapeutic Significance of Fibroblast Growth Factors.Targets (Basel)202541743400PubTator, text miningPubMed
Signaling of Mitogenic and Metabolic Activities by Fibroblast Growth Factors.J Cell Signal202541394119PubTator, text miningPubMed
FGF11 regulated by CTBP1-AS2/miR-520a-5p/miR-432-5p axis inhibits the progression and angiogenesis in high glucose-treated human microvascular endothelial cells.J Diabetes Investig202541385351PubTator, text miningPubMed
The Role of miR-326-3p in Regulating Differentiation and Thermogenesis Genes in Goat Brown Adipocytes.Genes (Basel)202541153426PubTator, text miningPubMed
FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation.Cells202541002392PubTator, text miningPubMed
Multiomic Analyses Reveal the Molecular Mechanisms of Arid Adaptation in a Desert Rodent Species.Mol Biol Evol202540974098PubTator, text miningPubMed
Impact of gestational and type 2 diabetes on fetal endothelial cell miRNA expression.J Diabetes Complications202540482554PubTator, text miningPubMed

1 to 10 of 416

See all 416 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2256

GET https://conductscience.org/api/genes/v1/2256/patents?page=2